Skip to main content
Membership NewsMembership News Archive

BIVDA meets with Genomics England, NHS England and the Office for Life Sciences to discuss future engagement on genomics

By April 1, 2022No Comments

This week Doris-Ann and the Chair of the Genomics Working Party, Dr Philip Beer, had a meeting with the Chief Executive of Genomics England (GEL), Chris Wigley, the deputy director for Genomics at NHS E&I, Alexandra Pickard and the head of Innovation & Growth at the OLS, Colin Wilson.

This as following the recent meeting with the working party to explore a relationship with GEL, and the Genomics Unit at NHS E&I, particularly how we can get genuinely disruptive tests into the system and re-design pathways to allow this given that the NHS focus is to pull through technologies that meet pre-identified areas of clinical need.

The timing was fortunate as NHS E&I are about to start work on their strategy for the next 3-5 years and will ensure BIVDA is brought into that process. There will be more investment into backstop funding from GEL and NHS E&I for research posts within the genomic laboratory hubs but it is hoped there will be industry engagement in this as well.

The meeting was a useful starting point to look at how we can potentially work with the genomic laboratories to assess new technologies and form partnerships for further development.